Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 8/20 | 0.88 |
| ▸ | PDE4B | Q07343 | 8/20 | 0.88 |
| ▸ | PDE4C | Q08493 | 8/20 | 0.88 |
| ▸ | PDE4D | Q08499 | 8/20 | 0.88 |
| ▸ | CYP2C9 | P11712 | 12/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4035651 | 0.94 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DCYP2C9 | |
| SCHEMBL4036015 | 0.90 | PDE4A (0.85) | PDE4APDE4BPDE4CPDE4DCYP2C9 | |
| SCHEMBL4037916 | 0.89 | PDE4A (0.72) | PDE4APDE4BPDE4CPDE4DCYP2C9 | |
| SCHEMBL4036040 | 0.89 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DCYP2C9 | |
| SCHEMBL4036998 | 0.87 | PDE4A (0.82) | PDE4APDE4BPDE4CPDE4DCYP2C9 | |
| SCHEMBL4037846 | 0.87 | PDE4A (0.85) | PDE4APDE4BPDE4CPDE4DCYP2C9 | |
| SCHEMBL4037982 | 0.85 | PDE4A (0.82) | PDE4APDE4BPDE4CPDE4DCYP2C9 | |
| SCHEMBL4038975 | 0.85 | PDE4A (0.78) | PDE4APDE4BPDE4CPDE4DCYP2C9 | |
| SCHEMBL4036118 | 0.84 | PDE4A (0.85) | PDE4APDE4BPDE4CPDE4DCYP2C9 | |
| SCHEMBL4037591 | 0.83 | PDE4A (0.81) | PDE4APDE4BPDE4CPDE4DCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1066286-B1 | HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2009-04-29 | — | — | EP | claimed |
| EP-1487797-A1 | HETERO-BRIDGE SUBSTITUTED 8-ARYLQUINOLINE PDE4 INHIBITORS | Merck Frosst Canada & Co. (CA) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003078397-A1 | HETERO-BRIDGE SUBSTITUTED 8-ARYLQUINOLINE PDE4 INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 2003-09-25 | — | — | WO | disclosed |